Name: RVMD Balance Sheet - Revolution Medicines Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

RVMD - Revolution Medicines, Inc.

USD | NASDAQ | Healthcare

RVMD Balance Sheet - Revolution Medicines Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Cash And Short Term Investments
Cash And Equivalents	383.7	543.1	696.1	161.4	108.5	104.3	16.7	69.6	-
Restricted Cash	-	-	-	-	-	-	-	-	-
Short Term Investments	1,641.9	1,746.2	1,156.8	483.5	468.6	336.5	106.1	-	-
Cash And Short Term Investments	2,025.7	2,289.3	1,853.0	644.9	577.1	440.7	122.8	69.6	-
Receivables
Accounts Receivable	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-
Prepaid Expenses	49.4	38.3	25.1	10.6	6.8
Non-Current Assets
Property, Plant & Equipment Gross	61.7	46.1	40.6	33.1	22.4	17.0	12.7	-	-
Accumulated Depreciation	28.5	21.8	17.7
Current Liabilities
Accounts Payable	64.6	54.4	61.8	21.3	14.1	12.6	11.4	-	-
Short Term Debt	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	142.2	123.0	80.6	57.4
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-
Additional Paid In Capital	-	-	-	-	-
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q4 FY 17
Cash And Short Term Investments
Cash And Equivalents	440.9	383.7	217.4	402.4	333.6	543.1	201.3	275.7	288.4	696.1	358.4	380.3	427.2	161.4	178.9

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	59.8	49.4	46.0	39.3	31.9	38.3	29.7	34.0	25.7	25.1	11.0	10.1	9.0	10.6	15.2	16.0	10.2	6.8
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	1,967.9	2,075.0	1,977.5	2,176.4	2,134.6	2,327.6	1,579.1	1,624.7	1,729.2	1,879.3	824.5	922.1	922.8	660.2	675.1	483.0

Non-Current Assets
Property, Plant & Equipment Gross	62.2	61.7	59.9	58.1	50.5	46.1	46.5	45.7	42.6	40.6	38.4	36.5	34.2	33.1	31.8	28.4	24.6	22.4	20.3	20.3	19.6	17.0	14.5	13.9	13.0	12.7	-	-	-	-	-
Accumulated Depreciation	30.7	28.5	27.0	25.0	23.4	21.8	21.7	20.5	18.9	17.7	18.1	16.8	15.7	14.5	13.5	12.5	11.6
Property,Plant & Equipment Net	31.5	33.2	32.9	33.0	27.2	24.3	24.8	25.3	23.7	22.9	20.3	19.7	18.5	18.7	18.3	15.9
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	14.6	14.6	14.6	14.6	14.6	14.6	14.6	14.6	14.6	14.6	14.6	14.6	14.6	14.6	14.6	14.6	14.6	14.6
Intangible Assets	55.8	55.8	55.9	56.1	56.4	56.7	56.9	57.2	57.5	57.7	58.0	58.3	58.5	58.8	58.5	59.3	59.6
Operating Lease Right Of Use Assets	129.9	132.1	134.5	114.0	115.8	117.5	74.3	75.3	76.2	77.1	53.1	53.7	54.3	55.1	56.3	57.4
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	14.5	14.8	14.9	31.4	13.1	1.7	10.3	8.3	4.2	7.0	11.4	2.7	2.8	2.9	0.9	0.7	0.9
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	2,253.7	2,354.5	2,251.9	2,429.6	2,365.4	2,558.3	1,763.0	1,808.4	1,908.4	2,061.7	984.2	1,073.7	1,073.2	811.9	825.9	632.8

Current Liabilities
Accounts Payable	80.5	64.6	74.8	56.8	47.5	54.4	24.5	29.3	32.4	61.8	29.6	29.8	19.9	21.3	24.4	14.1	14.2	14.1	10.5	10.4	9.7	12.6	6.7	10.2	7.9	11.4	-	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	0.0	0.0	1.4	4.5	9.7	9.7	11.4
Operating Lease Liabilities Current	16.6	16.5	16.3	13.1	13.0	12.9	8.4	8.3	8.2	7.4	5.8	5.7	5.9	6.8	7.0	6.0
Accrued Expenses	5.0	-	5.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Liabilities	3.3	7.9	8.2	0.5	0.7	0.6	1.3	0.7	0.7	3.9	0.5	0.4	0.4	0.5	0.5	0.6	0.3
Total Current Liabilities	289.6	290.4	245.6	184.5	158.6	163.9	110.9	105.3	93.7	143.9	85.5	78.1	54.6	62.0	73.3

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	140.0	142.2	142.1	119.7	121.4	123.0	78.3	79.1	79.9	80.6	57.1	57.5	57.7	57.4	58.2
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.4	3.8	5.7
Deferred Tax Liabilities	2.4	2.4	2.4	2.4	2.4	2.4	3.1	3.1	3.1	3.1	3.2	7.0	7.0	7.0	7.1	7.4	7.4
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	6.9	1.2	2.5	7.2	4.1	0.7	1.6	0.7	3.0	1.5	1.0	0.3	1.7	0.3	0.5	0.2
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	753.8	723.2	655.0	564.2	287.2	293.1	196.7	189.6	182.9	235.5	146.8	142.9	121.0	126.7	144.5	134.0

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-	-
Additional Paid In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	(3,322.9)	(2,869.1)	(2,504.2)	(2,199.0)	(1,951.2)	(1,737.8)	(1,543.2)	(1,386.9)	(1,253.7)	(1,137.7)	(976.2)	(867.7)	(769.4)	(701.3)	(644.8)	(571.5)	(510.3)
Accumulated Other Comprehensive Income	(0.6)	3.2	3.1	1.3	1.7	1.3	3.8	(1.9)	(1.2)	0.5	(0.9)	(1.3)	(0.6)	(1.8)	(2.4)	(1.8)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	1,499.9	1,631.3	1,596.9	1,865.4	2,078.2	2,265.2	1,566.3	1,618.8	1,725.5	1,826.2	837.5	930.8	952.2	685.2	681.4	498.8
Total Equity	1,499.9	1,631.3	1,596.9	1,865.4	2,078.2	2,265.2	1,566.3	1,618.8	1,725.5	1,826.2	837.5	930.8	952.2	685.2	681.4	498.8	551.0	602.6